Notify me when Tactic Pharma LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | Common Stock, $0.001 par value | 0% | $0 | -$33,051,150 | 0 | -100% | Tactic Pharma LLC | 28 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|